Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates

Go back to Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates

Vaxxinity, Inc. (VAXX) Reports In-Line Q4 EPS

March 27, 2023 7:51 AM EDT

Vaxxinity, Inc. (NASDAQ: VAXX) reported Q4 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Vaxxinity, Inc. (VAXX) click here.

... More